Clinical Trial Update: HERV-K Suppression Using Antiretroviral Therapy in Volunteers With Amyotrophic Lateral Sclerosis (ALS) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating suppression of HERV-K with antiretroviral therapy in volunteers with amyotrophic lateral sclerosis has completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis
• Amyotrophic Sclerosis

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Amyotrophic Lateral Sclerosis | Phase 1 | Status: COMPLETED | Results posted: 2024-01-09